A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R	S	T	U	V	W	X	Y	Z	AA	AB	AC	AD	AE	AF	AG	AH	AI	AJ	AK	AL	AM	AN	AO	AP	AQ	AR	AS	AT	AU	AV	AW	AX	AY	AZ	BA	BB	BC	BD	BE	BF	BG	BH
1	Main
2			Q119	Q219	Q319	Q419	Q120	Q220	Q320	Q420	Q121	Q221	Q321	Q421	Q122	Q222	Q322	Q422	Q123	Q223	Q323	Q423				2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	2036	2037	2038	2039	2040	2041	2042	2043	2044
3		Eylea	1074.1	1160			1172	1114	1318	1343	1347	1425	1473	1547	1518	1621	1629	1496	1669.8000000000002	1783.1000000000001	1791.9	1645.6000000000001														4947	5792	6264	6890.4000000000015
4		Libtayo	26.8	40.8			61.7	63.3	72	74	69	78	78	81	79	91	126	152	157	162	167	172														271	306	448	658
5		Praluent	0	26.5			0	47.2	49	55	43	42	45	40	34	31	30	36	37	38	39	40														151.2	170	131	154
6		Inmazeb/REGEN-COV	0	0			0	0	40	146	262	2591	677	2298	0	0	3	0	0	0	0	0														186	5828	3	0
7		Evkeeza	0	0			0	0	0	0	1	2	7	9	8	11	14	15	16	17	18	19														0	19	48	70
8		Arcalyst	3.5	4.2			3	2.7	3	4	3	0	0	0	0	0	0	0	0	0	0	0														12.7	3	0	0
9		Sanofi	0	0			246.9	269.1	353.3	317.1	364.80000000000007	437.7	581.8000000000001	517.9	630.9	677.5	711.4	835.9	820.17	880.75	853.68	1003.0799999999999														1186.4	1902.2000000000003	2855.7000000000003	3557.68
10		P&L Share					170.9	171.9	212.8	229.6	260.6	327.6	387	387.8	415.3	496.6	551.1	619																		785.2	1363	2082	0
11		Reimbursement					80.1	100.6	94.3	93	105.6	110.9	144.7	127.6	160.8	145.5	160.5	166.9																		368	488.79999999999995	633.7	0
12		Other					-4.1	-3.4000000000000004	46.199999999999996	-5.5	-1.3999999999999995	-0.7999999999999998	50.1	2.5	54.8	35.4	-0.2	50																		33.199999999999996	50.400000000000006	140	0
13		Dupixent		557.3			855	945	1072.6	1172	1262.9	1499	1662.9	1773.8	1810.4	2091.8	2330.1	2448.9																		4044.6	6198.6	8681.2	0
14		Praluent		73.7				86.6	91.5	100.9	104.6	99.4	114.5	102.6	111.4	108.9	113.7	133.4																		279	421.1	467.4	0
15		Kevzara		58.5				68.3	70	71.5	69.1	66.7	97.8	103.9	106.4	82.3	88.1	81.2																		209.8	337.5	357.99999999999994	0
16		Bayer	264				281.4	244.2	299.9	360.6	322.8	349	365	372.4	385.3	358	333	355.1	389.153	361.58	336.33	358.651														1186.1	1409.1999999999998	1431.4	1445.714
17		Roche	0	0	0	0	0	0	0	0	66.8	168	127.1	0	216.3	8	6	396.4	156.675	141.76875	175.2109375	217.513671875														0	361.9	626.7	691.168359375
18		Other	22.2				63.2	211.8	158.6		50	46	99	86.2	94	59	84	127.7	91.175	90.46875	98.3359375	101.919921875														433.6	281.2	364.7	381.899609375
19		Revenue	1390.6	1231.5			1828.2	1952.3000000000002	2293.7999999999997	2299.7	2529.4000000000005	5138.7	3452.9	4951.499999999999	2965.5000000000005	2856.5	2936.4	3414.1	3336.973000000001	3474.6675000000005	3479.456875	3557.76459375														8374	16072.500000000002	12172.500000000002	13848.861968750001
20		COGS		58.2			217.3	266.2	122	339.5	308	693.7	224	729.9	404.9	297.1	109	387.20000000000005	333.6972999999998	347.46675000000005	347.9456875000001	355.77645937499983														945	1955.6	1198.2	1384.8861968749998
21		Gross Margin					1610.9	1686.1000000000001	2171.7999999999997	1960.1999999999998	2221.4000000000005	4445	3228.9	4221.599999999999	2560.6000000000004	2559.4	2827.4	3026.8999999999996	3003.275700000001	3127.2007500000004	3131.5111875	3201.9881343750003														7429	14116.900000000001	10974.300000000001	12463.975771875
22		R&D		426.2			583.9	580.1	629	675	742.9	714.2	592	639	843.8	779.6999999999999	817	1041.6999999999998																		2468	2688.1	3482.2	0
23		SG&A		251.9			347.1	301.4	291	381	405.6	414.7	391	495	450	475.2	467	657	450	475.2	467	657														1320.5	1706.3	2049.2	2049.2
24		OpEx					931	881.5	920	1056	1148.5	1128.9	983	1134	1293.8	1254.8999999999999	1284	1698.6999999999998	450	475.2	467	657														3788.5	4394.4	5531.4	2049.2
25		OpInc					679.9000000000001	804.6000000000001	1251.7999999999997	904.1999999999998	1072.9000000000005	3316.1	2245.9	3087.5999999999995	1266.8000000000004	1304.5000000000002	1543.4	1328.1999999999998	2553.275700000001	2652.0007500000006	2664.5111875	2544.9881343750003														3640.5	9722.500000000002	5442.9000000000015	10414.775771875
26		Interest Expense					65.7	-42.300000000000004	-54.8	57.6	25.9	-45.7	-30.6	-120.50000000000001	-177.20000000000002	-164.1	32.6	97.4																		26.200000000000003	-170.90000000000003	-211.29999999999998	0
27		Pretax Income					745.6000000000001	762.3000000000002	1196.9999999999998	961.7999999999998	1098.8000000000006	3270.4	2215.3	2967.0999999999995	1089.6000000000004	1140.4000000000003	1576	1425.6	2553.275700000001	2652.0007500000006	2664.5111875	2544.9881343750003														3666.7	9551.600000000002	5231.600000000001	10414.775771875
28		Taxes					44	21.6	156.2	75.4	137.8	653.9	184.4	274.4	87.6	111.1	194.1	127.6	382.99135500000017	397.80011250000007	399.67667812499997	381.74822015625006														297.2	1250.5	520.4	1562.21636578125
29		Net Income					701.6000000000001	740.7000000000002	1040.7999999999997	886.3999999999999	961.0000000000007	2616.5	2030.9	2692.6999999999994	1002.0000000000003	1029.3000000000004	1381.9	1298	2170.284345000001	2254.2006375000005	2264.834509375	2163.23991421875														3369.5	8301.100000000002	4711.200000000002	8852.55940609375
30		EPS					6.09556907037359	6.208717518860018	9.137840210711147	7.900178253119428	8.572702943800184	23.319964349376114	17.830553116769096	23.787102473498226	8.73583260680035	8.919410745233971	12.250886524822697	11.385964912280702	19.03758197368422	19.773689802631583	19.866969380482455	18.975788721217107														29.268186753528777	73.55870624723084	41.244911359159566	77.65402987801535
31		Shares					115.1	119.3	113.9	112.2	112.1	112.2	113.9	113.2	114.7	115.4	112.8	114	114	114	114	114														115.12499999999999	112.85000000000001	114.22500000000001	114
32
33		Revenue y/y									0.3835466579148892	1.6321262101111507	0.5053186851512776	1.153106926990477	0.17241242982525495	-0.4441201081985716	-0.1495844073097976	-0.3104917701706552	0.12526487944697373	0.21640731664624546	0.18493967953957213	0.04207978493600084
34		Eylea y/y									0.14931740614334466	0.2791741472172351	0.11760242792109254	0.1518987341772151	0.12694877505567925	0.13754385964912275	0.10590631364562109	-0.03296703296703296	0.10000000000000009	0.10000000000000009	0.10000000000000009	0.10000000000000009
35		Sanofi y/y									0.4775212636695021	0.6265328874024525	0.6467591282196434	0.6332387259539576	0.7294407894736838	0.5478638336760338	0.22275696115503596	0.6140181502220505	0.30000000000000004	0.30000000000000004	0.19999999999999996	0.19999999999999996
36		Dupixent y/y									0.477076023391813	0.5862433862433862	0.5503449561812421	0.5134812286689419	0.4335260115606936	0.3954636424282856	0.40122677250586314	0.38059533205547424	-1	-1	-1	-1
37
38		Gross Margin					0.8811399190460563	0.863648004917277	0.9468131484872264	0.8523720485280689	0.878231991776706	0.8650047677428143	0.9351269947001072	0.8525901242047865	0.8634631596695329	0.8959915981095747	0.9628797166598556	0.8865879734044111	0.9000000000000001	0.9	0.9	0.9
39
40
41
42
43
44
45		Cash																14334.099999999999
46		AR																5328.7
47		Inventories																2401.9
48		Prepaids																411.2
49		PP&E																3763
50		Goodwill																915.5
51		Taxes																1723.7
52		ONCA																336.4
53		Assets																29214.500000000004
54
55		AP																589.2
56		AE																2074.2
57		DR																547.6999999999999
58		Debt																1981.4
59		Leases																720
60		ONCL																638
61		SE																22664
62		L+SE																29214.5